GPM GESTION ACTIVA, FI

Leaves the portfolio; it was 5.20% of weight.

Leaves the portfolio; it was 4.86% of weight.

Leaves the portfolio; it was 4.86% of weight.

Leaves the portfolio; it was 4.86% of weight.

Leaves the portfolio; it was 4.63% of weight.

Leaves the portfolio; it was 4.63% of weight.

Leaves the portfolio; it was 4.37% of weight.

Leaves the portfolio; it was 4.37% of weight.

Leaves the portfolio; it was 4.36% of weight.

Leaves the portfolio; it was 4.03% of weight.

Leaves the portfolio; it was 4.03% of weight.

Leaves the portfolio; it was 2.22% of weight.

Meliá Hotels International, S.A. owns, operates, manages, leases, and franchises hotels in Spain, Latin America, the rest of Europe, and Asia. It operates through Hotel Management, Hotel Business, Other Business Linked to Hotel Management, and Real Estate segments. The company operates hotels under the Gran Meliá Hotels & Resorts, the Meliá Collection, ME by Meliá, Paradisus by Meliá, Meliá Hotels & Resorts, INNSIDE by Meliá, ZEL, Sol by Meliá, Affiliated by Meliá brands, as well as Circle by Meliá and Club Meliá brands. It also engages in the operation of vacation club; casino or tour operation activities; and real estate business. In addition, the company offers Meliá Rewards; and Meliá PRO, a platform for professionals. The company was formerly known as Sol Meliá, S.A. and changed its name to Meliá Hotels International, S.A. in June 2011. The company was founded in 1956 and is headquartered in Palma de Mallorca, Spain.

Leaves the portfolio; it was 1.66% of weight.

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism, anti-infective for systemic use, cardiovascular system, dermatological, genito urinary system and sex hormones, immunostimulants, metabolism, musculo-skeletal system, nervous system, respiratory system, systemic hormonal preparations. It also develops tirbanibulin for actinic keratosis, and tildrakizumab for psoriatic arthritis under the registration phase, as well as lebrikizumab for atopic dermatitis pediatric in phase 2; Anti-IL-1RAP mAb for hidradenitis suppurativa, anti-IL-1RAP mAb for inflammatory skin disease, Anti-IL-21 mAb for hidradenitis suppurativa, IL-2muFc for alopecia areata, IL-2muFc for atopic dermatitis, and IL-2muFc for inflammatory skin disease in phase 2; readthrough inducer for rare dermatology in phase 1; and anti-IL-13/OX40L BsAb for atopic dermatitis, SMOL oral for Th2-driven diseases, and mRNA/LNP for non-melanoma skin cancer in preclinical stage. It has research and development agreements with Evotec, Ichnos, Simcere, Etherna, Novo Nordisk, and Eloxx. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Leaves the portfolio; it was 1.40% of weight.

ArcelorMittal S.A., together with its subsidiaries, operates as integrated steel and mining companies in the Americas, Europe, Asia, and Africa. It offers semi-finished flat products, including slabs; finished flat products comprising plates, hot- and cold-rolled coils and sheets, hot-dipped and electro-galvanized coils and sheets, tinplate, and color coated coils and sheets; semi-finished long products, such as blooms and billets; finished long products consisting of bars, wire-rods, structural sections, rails, sheet piles, and wire-products; and seamless and welded pipes and tubes. The company also provides mining products, such as iron ore lumps, fines, concentrate, pellets, and sinter feeds; and coking coal. It sells its products to various customers in the automotive, appliance, engineering, construction, energy, and machinery industries through a centralized marketing organization, and distributors. The company operates iron ore mining activities in Brazil, Bosnia, Liberia, Mexico, South Africa, and Ukraine, as well as in India and in Canada. ArcelorMittal S.A. was founded in 1976 and is headquartered in Luxembourg, Luxembourg.

Leaves the portfolio; it was 0.90% of weight.

Ebro Foods, S.A. operates as a food company in Spain, the Americas, Europe, and internationally. The company offers dry, fresh, frozen, organic, aromatic, and brown rice; premium, fresh, and filled pasta; ready-to-serve rice and pasta dishes; sauces; flours and ingredients; and canned vegetables. It sells its products under the Brillante, SOS, La Fallera, Santa Rita, La Cigala, Rocio, Santa Lucia, Arotz, Garofalo, Cigala, Bertagni, Russo, Ris-Fix, Königs Reis, Lustucru, Lassie, Tilda, Taureau Ailé, Boss, Oryza, Saludães, Mahatma, Riceland, Bosto, Adolphus, Minute, Reis-Fit, Gourmet House, Success, Risella, Herba, Blue Ribbon Rice, Casi, Pear Blossom, Rice Select, Carolina, Water Maid, River, AA, Ultimate, Wonder, Comet Rice, Peacock, Minute Rice, Colusa Rose, Kohinoor, Olivieri, Sello Rojo, In Harvest, Puroma, Miura, Abu Bint, Rix fis, and Phoenix brands. The company also engages in insurance and finance; administration; farmland concessionaire; rice farming; logistics; and investment management activities. It exports its products. The company was formerly known as Ebro Puleva, S.A. and changed its name to Ebro Foods, S.A. in June 2010. Ebro Foods, S.A. was incorporated in 1998 and is headquartered in Madrid, Spain.

Leaves the portfolio; it was 0.65% of weight.

Leaves the portfolio; it was 0.57% of weight.

Leaves the portfolio; it was 0.35% of weight.

Goes from 1.08% to 0.41%.

Sacyr, S.A. engages in the development and operation of infrastructure concessions worldwide. It is involved in the infrastructure development, such as transportation, sanitation, water, and waste treatment; development of large-scale civil engineering, industrial transport infrastructure, and building projects; water treatment, purification, desalination, purification, and reuse, as well as operation and maintenance of facilities. The company was formerly known as Sacyr Vallehermoso S.A. and changed its name to Sacyr, S.A. in August 2013. Sacyr, S.A. is based in Madrid, Spain.

Goes from 1.22% to 0.74%.

Técnicas Reunidas, S.A., an engineering and construction company, designs and manages industrial plant projects worldwide. It operates through Upstream & Refining, Natural gas, Petrochemical, Low-carbon technologies, and Other segments. The Refining segment offers management, engineering, procurement, construction and commissioning services for facilities along the entire value chain to produce fuels. The Natural gas segment provides direction, management, engineering, procurement, construction and commissioning services for facilities throughout the supply chain, from natural gas production to regasification terminals; and treatment and processing plants, compressor and liquefaction stations, storage tanks, and final regasification facilities. The Petrochemical segment provides direction, management, engineering, procurement, construction and startup services for facilities dedicated to the production of basic chemical materials used in water distribution, pharmaceuticals, health, food, energy efficiency in buildings and transport systems, and others. The Low-carbon technologies segment offers hydrogen, carbon capture and storage, circular economy and bioproducts; produces biomethane and converts biomass and waste into fuels, biodiesel, biokerosene, chemicals, and power and steam generation. The Other segment offers water treatment, port infrastructures, and oil production. In addition, the company is involved in real estate-related activities, consultancy and assistance in international engineering projects, project execution, and machinery wholesale business. Técnicas Reunidas, S.A. was formerly known as Lummus Española, S.A. and changed its name to Técnicas Reunidas, S.A. in 1972. The company was incorporated in 1960 and is headquartered in Madrid, Spain.

Goes from 2.06% to 1.76%.